BIOCARDIA INC's ticker is BCDAW and the CUSIP is 09060U119. A total of 6 filers reported holding BIOCARDIA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,434 | -66.6% | 5,735 | 0.0% | 0.00% | – |
| Q2 2023 | $4,296 | -9.7% | 5,735 | 0.0% | 0.00% | – |
| Q1 2023 | $4,760 | +0.5% | 5,735 | 0.0% | 0.00% | – |
| Q4 2022 | $4,737 | +373.7% | 5,735 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 5,735 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 5,735 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -66.7% | 5,735 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | – | 5,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 18,459 | $20,000 | 0.04% |
| CAPTRUST FINANCIAL ADVISORS | 500,000 | $555,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 53,530 | $59,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,735 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,067 | $1,000 | 0.00% |